Trial Profile
A Phase III Trial Comparing Whole Brain Radiation (WBRT) and Stereotactic Radiosurgery (SRS) Alone Versus With Temozolomide or Erlotinib in Patients With Non-Small Cell Lung Cancer and 1-3 Brain Metastases
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Erlotinib (Primary) ; Temozolomide (Primary)
- Indications Brain metastases; Non-small cell lung cancer
- Focus Therapeutic Use
- 02 Feb 2017 New trial record